Literature DB >> 7501116

Steroid hormone receptors in astrocytic neoplasms.

R S Carroll1, J Zhang, K Dashner, M Sar, P M Black.   

Abstract

The presence of specific steroid hormone-binding receptors has been correlated with the clinical response to hormonal therapy in a number of different neoplasias, including breast and prostate cancer. In this article, we investigated the expression of the androgen, estrogen, glucocorticoid, and progesterone receptor messenger ribonucleic acid (mRNA) and protein in a number of astrocytic neoplasms of various histological grades. Androgen and glucocorticoid receptor mRNA were detected in all astrocytic neoplasms examined, regardless of histological subtype. In contrast, progesterone receptor mRNA was observed more frequently in high-grade tumors than in low-grade tumors. Estrogen receptor mRNA was undetectable in all astrocytic tumors examined. These studies suggest a possible adjunct clinical use of hormonal therapy for the treatment of astrocytomas. Specific antagonists and agonists may allow the modulation of the growth of these tumors. Development of this body of knowledge may lead to the development of better treatment for these aggressive tumors.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7501116     DOI: 10.1227/00006123-199509000-00019

Source DB:  PubMed          Journal:  Neurosurgery        ISSN: 0148-396X            Impact factor:   4.654


  36 in total

Review 1.  Possible effects of progesterone on human central nervous system and neurogenic tumors.

Authors:  T Inoue; H Sasano
Journal:  J Endocrinol Invest       Date:  2004-01       Impact factor: 4.256

2.  Progesterone and estradiol effects on SRC-1 and SRC-3 expression in human astrocytoma cell lines.

Authors:  Olivia Tania Hernández-Hernández; Mauricio Rodríguez-Dorantes; Aliesha González-Arenas; Ignacio Camacho-Arroyo
Journal:  Endocrine       Date:  2009-12-05       Impact factor: 3.633

3.  Reproductive factors and exogenous hormone use and risk of adult glioma in women in the NIH-AARP Diet and Health Study.

Authors:  Geoffrey C Kabat; Yikyung Park; Albert R Hollenbeck; Arthur Schatzkin; Thomas E Rohan
Journal:  Int J Cancer       Date:  2011-02-15       Impact factor: 7.396

4.  Estrogen receptor beta (ERbeta) protein expression correlates with BAG-1 and prognosis in brain glial tumours.

Authors:  Anna Batistatou; Panayiotis A Kyzas; Ann Goussia; Evdokia Arkoumani; Spyridon Voulgaris; Konstantinos Polyzoidis; Niki J Agnantis; Dimitrios Stefanou
Journal:  J Neurooncol       Date:  2005-11-15       Impact factor: 4.130

5.  Therapeutic significance of estrogen receptor β agonists in gliomas.

Authors:  Gangadhara R Sareddy; Binoj C Nair; Vijay K Gonugunta; Quan-guang Zhang; Andrew Brenner; Darrell W Brann; Rajeshwar Rao Tekmal; Ratna K Vadlamudi
Journal:  Mol Cancer Ther       Date:  2012-03-21       Impact factor: 6.261

6.  Prognostic value of novel biomarkers in astrocytic brain tumors: nuclear receptor co-regulators AIB1, TIF2, and PELP1 are associated with high tumor grade and worse patient prognosis.

Authors:  Zinovia Kefalopoulou; Vassiliki Tzelepi; Vassiliki Zolota; Petros D Grivas; Christos Christopoulos; Haralabos Kalofonos; Theodoros Maraziotis; Georgia Sotiropoulou-Bonikou
Journal:  J Neurooncol       Date:  2011-07-07       Impact factor: 4.130

7.  Androgen receptor signaling regulates growth of glioblastoma multiforme in men.

Authors:  Xiaoming Yu; Yuhua Jiang; Wei Wei; Ping Cong; Yinlu Ding; Lei Xiang; Kang Wu
Journal:  Tumour Biol       Date:  2014-10-15

8.  Expression of corticosteroid-binding globulin in human astrocytoma cell line.

Authors:  Larissa Pusch; Sonja Wegmann; Jack D Caldwell; Gustav F Jirikowski
Journal:  Cell Mol Neurobiol       Date:  2009-01-27       Impact factor: 5.046

Review 9.  Cancer therapy using natural ligands that target estrogen receptor beta.

Authors:  Gangadhara R Sareddy; Ratna K Vadlamudi
Journal:  Chin J Nat Med       Date:  2015-11

10.  Expression of estrogen and progesterone receptors in vestibular schwannomas and their clinical significance.

Authors:  Sushila Jaiswal; Vinita Agrawal; Awadhesh Kumar Jaiswal; Rakesh Pandey; Ashok Kumar Mahapatra
Journal:  J Negat Results Biomed       Date:  2009-11-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.